期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 18, 期 13, 页码 2626-2634出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.2000.18.13.2626
关键词
-
类别
Shortening of the telomeric DNA at chromosome ends is postulated to limit the lifespan of human cells. In contrast, activation of telomerase, the enzyme that synthesizes telomeric DNA, is proposed to be an essential step in cancer cell immortalization and cancer progression. This review discusses the structure and function of telomeres and telomerase, the role of telomerase in cell immortalization, and the effects of telomerase inactivation on normal and cancer cells. Moreover, data on the experimental use of telomerase assays for cancer detection and diagnosis are reviewed. Finally, the review considers the evidence regarding whether telomerase inhibitors could be used to treat human cancers. J Clin Oncol 78:2626-2634. (C) 2000 by American Society of Clinical Oncology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据